Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Langmuir ; 34(44): 13144-13154, 2018 11 06.
Artigo em Inglês | MEDLINE | ID: mdl-30336055

RESUMO

In this study, composite photocatalysts were produced from NiTiO3 and N2-rich precursors (dicyandiamide, melamine, urea, and thiourea) under N2 flow conditions. The goal of the study was to investigate the interaction between NiTiO3 and the synthesized g-C3N4. The properties of the g-C3N4/NiTiO3 (CNT) composites were different depending on the starting materials. Dicyandiamide and thiourea created strong connections with NiTiO3 and resulted in the generation of Ti-N and Ti-O-S bonds. Urea and melamine, however, had difficulty forming g-C3N4 structures or interconnections with NiTiO3. The Ti-N and Ti-O-S bridges in the composite photocatalysts led to increased photocatalytic activity as well as inhibition of the recombination rate. Additionally, the band diagrams of g-C3N4 prepared from dicyandiamide and thiourea exhibited positions suitable for the Z-scheme charge-transfer model with NiTiO3, implying that the composite photocatalysts were applicable for photocatalytic degradation of organic contaminants under the visible-light irradiation. Higher reaction rate constants for the composites prepared with dicyandiamide and thiourea confirmed the significant role of the Ti-N/Ti-O-S bridge between g-C3N4 and NiTiO3.

2.
Bioorg Med Chem Lett ; 27(16): 3629-3635, 2017 08 15.
Artigo em Inglês | MEDLINE | ID: mdl-28729055

RESUMO

In 2014, a published report of the high-throughput screen of>42,000 kinase inhibitors from GlaxoSmithKline against T. brucei identified 797 potent and selective hits. From this rich data set, we selected NEU-0001101 (1) for hit-to-lead optimization. Through our preliminary compound synthesis and SAR studies, we have confirmed the previously reported activity of 1 in a T. brucei cell proliferation assay and have identified alternative groups to replace the pyridyl ring in 1. Pyrazole 24 achieves improvements in both potency and lipophilicity relative to 1, while also showing good in vitro metabolic stability. The SAR developed on 24 provides new directions for further optimization of this novel scaffold for anti-trypanosomal drug discovery.


Assuntos
Desenho de Fármacos , Pirazóis/síntese química , Quinazolinonas/química , Tripanossomicidas/síntese química , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Humanos , Pirazóis/farmacologia , Pirazóis/uso terapêutico , Quinazolinonas/síntese química , Quinazolinonas/farmacologia , Quinazolinonas/uso terapêutico , Relação Estrutura-Atividade , Tripanossomicidas/farmacologia , Tripanossomicidas/uso terapêutico , Trypanosoma brucei brucei/efeitos dos fármacos , Trypanosoma brucei brucei/crescimento & desenvolvimento , Tripanossomíase Africana/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA